Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 43, Issue 1, Pages 142-154
Publisher
Springer Nature
Online
2017-09-07
DOI
10.1038/npp.2017.209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The current status of artisanal cannabis for the treatment of epilepsy in the United States
- (2017) Dustin Sulak et al. EPILEPSY & BEHAVIOR
- Cannabinoids in treatment-resistant epilepsy: A review
- (2017) Brooke K. O'Connell et al. EPILEPSY & BEHAVIOR
- Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys
- (2017) William S John et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
- (2016) A.G. Sartim et al. BEHAVIOURAL BRAIN RESEARCH
- Enhanced discriminative stimulus effects of Δ9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys
- (2016) Lance R. McMahon DRUG AND ALCOHOL DEPENDENCE
- Sex-dependent effects of cannabis-induced analgesia
- (2016) Ziva D. Cooper et al. DRUG AND ALCOHOL DEPENDENCE
- Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.
- (2016) David S. Jacobs et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
- (2016) C Mokrysz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Inhaled delivery of Δ 9 -tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology
- (2016) Jacques D. Nguyen et al. NEUROPHARMACOLOGY
- Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies
- (2016) Nicholas J. Jackson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9-tetrahydrocannabinol in Sprague-Dawley rats
- (2015) Michael A Taffe et al. BRITISH JOURNAL OF PHARMACOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neural correlates of interactions between cannabidiol and Δ9-tetrahydrocannabinol in mice: implications for medical cannabis
- (2015) S M Todd et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption
- (2015) Cristina A.J. Stern et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
- (2015) Chandni Hindocha et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Endocannabinoid signalling in reward and addiction
- (2015) Loren H. Parsons et al. NATURE REVIEWS NEUROSCIENCE
- Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
- (2015) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse
- (2015) Zuzana Justinova et al. NEUROPSYCHOPHARMACOLOGY
- Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
- (2015) Matthijs G. Bossong et al. PSYCHOPHARMACOLOGY
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- The case for medical marijuana in epilepsy
- (2014) Edward Maa et al. EPILEPSIA
- Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
- (2014) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model
- (2014) Timothy W. Lefever et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A vapourized Δ9-tetrahydrocannabinol (Δ9-THC) delivery system part II: Comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents
- (2014) Laurie A. Manwell et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol
- (2013) M Jerry Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
- (2013) M.V. Fogaça et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol reverses the mCPP-induced increase in marble-burying behavior
- (2013) Mirella Nardo et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity
- (2013) Vicky Katsidoni et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Spicing things up: synthetic cannabinoids
- (2013) Max Spaderna et al. PSYCHOPHARMACOLOGY
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol?
- (2012) Daniël Kleinloog et al. JOURNAL OF PSYCHOPHARMACOLOGY
- On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment
- (2012) Cristina A J Stern et al. NEUROPSYCHOPHARMACOLOGY
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Persistent cannabis users show neuropsychological decline from childhood to midlife
- (2012) M. H. Meier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
- (2011) E L Karschner et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Heterogeneity in the composition of marijuana seized in California
- (2011) James Richard Burgdorf et al. DRUG AND ALCOHOL DEPENDENCE
- Sativex®(tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data
- (2011) Patrick Vermersch Expert Review of Neurotherapeutics
- Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation
- (2011) P. D. Morrison et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity
- (2011) Robert E. Hampson et al. NEUROPHARMACOLOGY
- Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys
- (2011) M.A. Taffe NEUROSCIENCE
- Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential
- (2011) Andreas M. Stadelmann et al. NEUROSCIENCE LETTERS
- Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
- (2011) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
- (2011) Charlotte Klein et al. PSYCHOPHARMACOLOGY
- Interaction between cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids
- (2011) Antonio Waldo Zuardi et al. PSYCHOPHARMACOLOGY
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells
- (2010) Qiang Li et al. BRAIN RESEARCH
- Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
- (2010) I Magen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal models of cannabinoid reward
- (2010) Leigh V Panlilio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
- (2010) Sabatino Maione et al. BRITISH JOURNAL OF PHARMACOLOGY
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Plasma Cannabinoid Pharmacokinetics following Controlled Oral 9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
- (2010) E. L. Karschner et al. CLINICAL CHEMISTRY
- Retrograde Endocannabinoid Signaling Reduces GABAergic Synaptic Transmission to Gonadotropin-Releasing Hormone Neurons
- (2010) Imre Farkas et al. ENDOCRINOLOGY
- Central nervous system effects of haloperidol on THC in healthy male volunteers
- (2010) M Liem-Moolenaar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors
- (2010) Felipe V Gomes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- (2010) Celia JA Morgan et al. NEUROPSYCHOPHARMACOLOGY
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- (2009) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- 5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- (2009) Leonardo B.M. Resstel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- (2009) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol
- (2009) Paolo Fusar-Poli et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
- (2009) Luciano De Petrocellis et al. Journal of Neuroimmune Pharmacology
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats
- (2009) Daniel Thomas Malone et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
- (2009) P. D. Morrison et al. PSYCHOLOGICAL MEDICINE
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
- (2008) Stefan J. Borgwardt et al. BIOLOGICAL PSYCHIATRY
- Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats
- (2008) Michael S. Smirnov et al. BRAIN RESEARCH
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol
- (2008) Robert E. Vann et al. DRUG AND ALCOHOL DEPENDENCE
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
- (2007) Kazuhide Hayakawa et al. BRAIN RESEARCH
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- CB2receptors in the brain: role in central immune function
- (2007) G A Cabral et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started